Delivery Order SPE2DB20D7066-SPE2DB24FC2GB

Award Date 6/11/24
Potential Completion Date 6/12/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,028.77 under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of 4563849930 MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen's IDC with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense. The contract, valued at $1,261.92, is for the delivery of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,260.78 firm-fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.74 firm fixed-price delivery order is for the supply of Mesalamine DR 1.2 GM Tablet 120S, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen maintains a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,355.58 firm fixed-price delivery order is for the supply of 180 count bottles of 800 mg delayed-release mesalamine tablets, with a completion date of March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award, valued at $10,328.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for MESALAMINE DR 1.2 GM TABLET 120S, with a firm fixed price and an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,654.17 firm-fixed-price delivery order is for the supply of 180-count bottles of Mesalamine 800 mg delayed-release tablets. This contract item supports the medical needs of the U.S. Department of Defense and likely serves military treatment facilities and other government healthcare programs. The award is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $11,100.72 firm fixed price delivery order is for the supply of mesalamine delayed-release tablets, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award, valued at $83,765.48, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award, valued at $13,177.16, was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB24FC2GB
    Delivery Order

This federal contract award is for $3,192.04 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The contract is a delivery order with a firm fixed price, awarded by the Defense Logistics Agency (DLA) to provide Mesalamine DR 1.2 GM Tablet 120S.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's extensive experience and capability in pharmaceutical distribution for government agencies has enabled it to secure these high-value IDCs and individual delivery orders to support the medical needs of the U.S. Armed Forces and other federal agencies.

Generated 9/10/24, 11:10 AM